This site is intended for US healthcare professionals only. Visit Patient Site

Holly Robinson Peete didn't settle for just coping with overactive bladder (OAB)

She got proactive, listened to her body and her doctor, and started GEMTESA to help manage that frequent “gotta go” feeling. She is a true “go‑getter” — after sticking with treatment for over a year, she continues to improvement in her symptoms and is able to do more of what she loves with fewer trips to the bathroom.

Holly is a real patient taking GEMTESA who has been compensated for her time.

Ready to prioritize your bladder health?

Use the self-assessment tool to review your symptoms and discuss the results with your doctor.

Get going with Holly and the

GEMTESA Go-Getters

Transcript

“As a busy mom, actress, traveler, and advocate, my life is go, go, go. But when overactive bladder–OAB–made it so that all I could think about was, ‘I gotta go, go, go to the bathroom,' I knew I had to make a change.”

[Text on screen] Holly Robinson Peete Actor, real OAB patient, and GEMTESA spokesperson

Holly Robinson Peete is a real patient taking GEMTESA who has been compensated for her participation.

“Luckily, I listened to some of my girlfriends, my body, and, most importantly, my doctor, and found GEMTESA to help manage my OAB symptoms.”

“GEMTESA is a prescription medication for the treatment of overactive bladder in adults with symptoms of leakage episodes, urgency, and frequency.”

[Text on screen] GEMTESA is a prescription medication for the treatment of overactive bladder (OAB) in adults with symptoms of leakage episodes, urgency, and frequency.

“Do not take GEMTESA if you are allergic to vibegron or any of the ingredients in GEMTESA.”

“GEMTESA may cause serious side effects such as increasing your chances of not being able to empty your bladder.”

[Text on screen] GEMTESA may cause serious side effects such as increasing your chances of not being able to empty your bladder. Tell your doctor right away if you are unable to empty your bladder.

“My doctor told me the most common side effects may including headache, urinary tract infection, and common cold symptoms.”

[Text on screen] Most common side effects include headache, urinary tract infection, nasal congestion, sore throat or runny nose, diarrhea, nausea, and upper respiratory tract infection. Please see Important Safety Information at the end of this video.

“That was over a year ago, and now I'm making it my mission to change what ‘go, go, go,' means in my life and share my experience with others.”

“That's why I became a GEMTESA Go-Getter.”

“A Go-Getter is someone who refuses to let their lives revolve around the bathroom.”

[Text on screen] Quality time with friends

“And it's especially important to spread the word because I know so well that speaking up helps others feel seen and heard.”

“So, help me reframe the go, go, go. I hope you'll: Go — ask your doctor about GEMTESA”

[Text on screen] GO—ask your doctor about [logo] GEMTESA® (vibegron) 75 mg tablets

“Go — talk about your symptoms and explore treatment options”

[Text on screen] GO—talk about your symptoms and explore treatment options

“And Go — become a Go-Getter yourself.”

[Text on screen] Go—become a GO-GETTER yourself.

“Personally, life with GEMTESA means I am comfortable sitting further from the bathroom.”

“So come on, it's time to GO do something about OAB symptoms and become a GEMTESA Go-Getter yourself.”

[Text on screen] TIME TO GO

If you're struggling with OAB symptoms, use the self-assessment tool to start a discussion with your doctor.

Full Prescribing Information can be found at GEMTESA.com/PI

“If you're struggling with OAB symptoms, use the self-assessment tool to start a discussion with your doctor.”

[Narrator voice-over]

IMPORTANT SAFETY INFORMATION

Do not take GEMTESA® (vibegron) if you are allergic to vibegron or any of the ingredients in GEMTESA.

Before you take GEMTESA, tell your doctor about all your medical conditions, including if you have liver problems; have kidney problems; have trouble emptying your bladder or you have a weak urine stream; take medicines that contain digoxin; are pregnant or plan to become pregnant (it is not known if GEMTESA will harm your unborn baby; talk to your doctor if you are pregnant or plan to become pregnant); are breastfeeding or plan to breastfeed (it is not known if GEMTESA passes into your breast milk; talk to your doctor about the best way to feed your baby if you take GEMTESA).

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.

What are the possible side effects of GEMTESA?

GEMTESA may cause serious side effects including the inability to empty your bladder (urinary retention). GEMTESA may increase your chances of not being able to empty your bladder, especially if you have bladder outlet obstruction or take other medicines for treatment of overactive bladder. Tell your doctor right away if you are unable to empty your bladder.

The most common side effects of GEMTESA include headache, urinary tract infection, nasal congestion, sore throat or runny nose, diarrhea, nausea and upper respiratory tract infection. These are not all the possible side effects of GEMTESA. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is GEMTESA?

GEMTESA is a prescription medicine for adults used to treat the following symptoms due to a condition called overactive bladder: • urge urinary incontinence: a strong need to urinate with leaking or wetting accidents • urgency: the need to urinate right away • frequency: urinating often It is not known if GEMTESA is safe and effective in children.

Please see full Prescribing Information at www.GEMTESA.com/PI.

Being a GEMTESA Go‑Getter is so important to me

because I can spread awareness about OAB, rally others to care about their own bladder health, and open up the conversation. When you share stories, you never know what you might discover. I know how powerful advocacy can be — it can help others feel seen and heard.”

holly signature

It really hit me that GEMTESA was working when I noticed I was spending more time touring the sights and less time touring the city's bathrooms.

Holly's name

Actor, real OAB patient, and GEMTESA spokesperson.

Holly Robinson Peete with her husband.

I love shopping, and I can really get my retail therapy when I'm not as worried about dashing to the bathroom!

Diane's name

Diane is a real patient taking GEMTESA who has been compensated for her time.

Diane is a real patient taking GEMTESA®.

Are you a GEMTESA Go‑Getter?

By sharing your GEMTESA story, you can help break the stigma of living with OAB and inspire other patients to GO GET help. After you submit your info, you'll be contacted by one of our partners and your story may be featured here or on our social media channels!

Thank you for your interest in sharing your experience with GEMTESA for use in our promotional activities. By contacting us, you confirm that you:

  • Are over the age of 18
  • Live in the United States
  • Have been diagnosed with overactive bladder (OAB)
  • Have been prescribed GEMTESA for overactive bladder
  • Are currently taking GEMTESA as prescribed by your healthcare provider

Follow us:

Sign up to see if you're eligible for savings and more.

Holly Robinson Peete holding GEMTESA® pill bottle.
 

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

GEMTESA is contraindicated in patients with known hypersensitivity to vibegron or any components of the product.

WARNINGS AND PRECAUTIONS

Urinary Retention

Urinary retention has been reported in patients taking GEMTESA. The risk of urinary retention may be increased in patients with bladder outlet obstruction and also in patients taking muscarinic antagonist medications for the treatment of OAB. Monitor patients for signs and symptoms of urinary retention, particularly in patients with bladder outlet obstruction and patients taking muscarinic antagonist medications for the treatment of OAB. Discontinue GEMTESA in patients who develop urinary retention.

ADVERSE REACTIONS

Most common adverse reactions (2%) reported with GEMTESA were headache, urinary tract infection, nasopharyngitis, diarrhea, nausea, and upper respiratory tract infection.

 

INDICATIONS AND USAGE

GEMTESA® is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

GEMTESA is contraindicated in patients with known hypersensitivity to vibegron or any components of the product.

WARNINGS AND PRECAUTIONS

Urinary Retention

Urinary retention has been reported in patients taking GEMTESA. The risk of urinary retention may be increased in patients with bladder outlet obstruction and also in patients taking muscarinic antagonist medications for the treatment of OAB. Monitor patients for signs and symptoms of urinary retention, particularly in patients with bladder outlet obstruction and patients taking muscarinic antagonist medications for the treatment of OAB. Discontinue GEMTESA in patients who develop urinary retention.

ADVERSE REACTIONS

Most common adverse reactions (2%) reported with GEMTESA were headache, urinary tract infection, nasopharyngitis, diarrhea, nausea, and upper respiratory tract infection.

Please see full Prescribing Information.

You are encouraged to report side effects and product complaints associated with GEMTESA by calling 1-833-876-8268.

Sumitomo Pharma logo.

is a trademark of Sumitomo Pharma Co., Ltd., used under license. SUMITOMO PHARMA is a trademark of Sumitomo Pharma Co., Ltd., used under license. SUMITOMO is a registered trademark of Sumitomo Chemical Co., Ltd., used under license. Sumitomo Pharma America, Inc. is a U.S. subsidiary of Sumitomo Pharma Co., Ltd.

GEMTESA, and the GEMTESA logo are trademarks of Urovant Sciences GmbH, registered in the U.S. and in other countries.

©2024 Sumitomo Pharma America, Inc. All rights reserved. GEM-US-2138-24 09/24

IMPORTANT SAFETY INFORMATION

Do not take GEMTESA if you are allergic to vibegron or any of the ingredients in GEMTESA.

Before you take GEMTESA, tell your doctor about all your medical conditions, including if you have liver problems; have kidney problems; have trouble emptying your bladder or you have a weak urine stream; take medicines that contain digoxin; are pregnant or plan to become pregnant (it is not known if GEMTESA will harm your unborn baby; talk to your doctor if you are pregnant or plan to become pregnant); are breastfeeding or plan to breastfeed (it is not known if GEMTESA passes into your breast milk; talk to your doctor about the best way to feed your baby if you take GEMTESA).

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.

What are the possible side effects of GEMTESA?
GEMTESA may cause serious side effects including the inability to empty your bladder (urinary retention). GEMTESA may increase your chances of not being able to empty your bladder, especially if you have bladder outlet obstruction or take other medicines for treatment of overactive bladder. Tell your doctor right away if you are unable to empty your bladder.

The most common side effects of GEMTESA include headache, urinary tract infection, nasal congestion, sore throat or runny nose, diarrhea, nausea and upper respiratory tract infection. These are not all the possible side effects of GEMTESA. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Prescribing Information.

What is GEMTESA?

GEMTESA is a prescription medicine for adults used to treat the following symptoms due to a condition called overactive bladder:

  • urge urinary incontinence: a strong need to urinate with leaking or wetting accidents
  • urgency: the need to urinate right away
  • frequency: urinating often

It is not known if GEMTESA is safe and effective in children.

IMPORTANT SAFETY INFORMATION

Do not take GEMTESA if you are allergic to vibegron or any of the ingredients in GEMTESA.

Before you take GEMTESA, tell your doctor about all your medical conditions, including if you have liver problems; have kidney problems; have trouble emptying your bladder or you have a weak urine stream; take medicines that contain digoxin; are pregnant or plan to become pregnant (it is not known if GEMTESA will harm your unborn baby; talk to your doctor if you are pregnant or plan to become pregnant); are breastfeeding or plan to breastfeed (it is not known if GEMTESA passes into your breast milk; talk to your doctor about the best way to feed your baby if you take GEMTESA).

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.

What are the possible side effects of GEMTESA?
GEMTESA may cause serious side effects including the inability to empty your bladder (urinary retention). GEMTESA may increase your chances of not being able to empty your bladder, especially if you have bladder outlet obstruction or take other medicines for treatment of overactive bladder. Tell your doctor right away if you are unable to empty your bladder.

The most common side effects of GEMTESA include headache, urinary tract infection, nasal congestion, sore throat or runny nose, diarrhea, nausea and upper respiratory tract infection. These are not all the possible side effects of GEMTESA. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Prescribing Information.

You are encouraged to report side effects and product complaints associated with GEMTESA by calling 1-833-876-8268.

Sumitomo Pharma logo

is a trademark of Sumitomo Pharma Co., Ltd., used under license. SUMITOMO PHARMA is a trademark of Sumitomo Pharma Co., Ltd., used under license. SUMITOMO is a registered trademark of Sumitomo Chemical Co., Ltd., used under license. Sumitomo Pharma America, Inc. is a U.S. subsidiary of Sumitomo Pharma Co., Ltd.

GEMTESA, and the GEMTESA logo are trademarks of Urovant Sciences GmbH, registered in the U.S. and in other countries.

©2024 Sumitomo Pharma America, Inc. All rights reserved. GEM-US-2115-24 09/24